TipRanks
Dimed S.A. Distribuidora de Medicamentos (BR:PNVL3)
:PNVL3
Brazil Market
PNVL3
Dimed S.A. Distribuidora de Medicamentos
RESEARCH TOOLSreports

Dimed S.A. Distribuidora de Medicamentos (PNVL3) Ratios

― Followers

Dimed S.A. Distribuidora de Medicamentos Ratios

BR:PNVL3's free cash flow for Q2 2026 was R$0.29. For the 2026 fiscal year, BR:PNVL3's free cash flow was decreased by R$ and operating cash flow was R$0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.75 1.74 1.70 1.62 1.55
Quick Ratio
 0.78 0.86 0.73 0.74 0.66
Cash Ratio
 0.05 0.03 0.07 0.02 0.03
Solvency Ratio
 0.16 0.14 0.15 0.15 0.17
Operating Cash Flow Ratio
 0.29 0.32 0.19 0.26 0.20
Short-Term Operating Cash Flow Coverage
 1.27 2.20 1.38 2.89 1.74
Net Current Asset Value
R$ -207.59MR$ -251.07MR$ -130.16MR$ -63.99MR$ -66.42M
Leverage Ratios
Debt-to-Assets Ratio
 0.38 0.39 0.37 0.33 0.32
Debt-to-Equity Ratio
 1.07 1.18 1.00 0.87 0.79
Debt-to-Capital Ratio
 0.52 0.54 0.50 0.47 0.44
Long-Term Debt-to-Capital Ratio
 0.26 0.29 0.24 0.19 0.10
Financial Leverage Ratio
 2.82 2.99 2.74 2.62 2.47
Debt Service Coverage Ratio
 1.13 1.36 1.52 1.93 1.78
Interest Coverage Ratio
 1.74 1.72 1.71 1.62 1.88
Debt to Market Cap
 0.50 0.40 0.42 0.20 0.17
Interest Debt Per Share
 10.43 11.04 9.05 7.57 6.36
Net Debt to EBITDA
 2.58 3.11 2.70 2.52 2.54
Profitability Margins
Gross Profit Margin
28.23%28.17%31.79%30.87%31.14%
EBIT Margin
4.74%4.32%4.40%4.35%3.72%
EBITDA Margin
8.84%8.54%8.65%8.84%8.35%
Operating Profit Margin
4.56%4.32%3.95%3.73%3.44%
Pretax Profit Margin
2.73%2.64%2.28%2.05%1.97%
Net Profit Margin
2.33%2.26%2.13%2.08%2.16%
Continuous Operations Profit Margin
2.33%2.26%2.13%2.08%2.16%
Net Income Per EBT
85.39%85.62%93.73%101.44%110.09%
EBT Per EBIT
59.93%61.08%57.64%54.98%57.13%
Return on Assets (ROA)
3.71%3.25%3.12%3.02%3.16%
Return on Equity (ROE)
10.66%9.72%8.55%7.92%7.79%
Return on Capital Employed (ROCE)
10.93%9.49%8.91%8.57%7.96%
Return on Invested Capital (ROIC)
8.36%7.19%7.36%7.54%6.88%
Return on Tangible Assets
3.82%3.35%3.22%3.10%3.25%
Earnings Yield
9.14%6.97%8.04%4.95%6.34%
Efficiency Ratios
Receivables Turnover
 8.68 7.87 8.55 7.96 8.59
Payables Turnover
 6.57 5.46 5.34 4.54 4.95
Inventory Turnover
 3.51 3.39 2.93 3.09 3.07
Fixed Asset Turnover
 4.42 4.13 4.21 4.13 3.86
Asset Turnover
 1.59 1.44 1.46 1.45 1.46
Working Capital Turnover Ratio
 6.22 6.11 6.45 7.10 7.06
Cash Conversion Cycle
 90.36 87.04 99.06 83.68 87.81
Days of Sales Outstanding
 42.06 46.36 42.69 45.85 42.51
Days of Inventory Outstanding
 103.86 107.55 124.67 118.29 119.08
Days of Payables Outstanding
 55.55 66.87 68.30 80.46 73.78
Operating Cycle
 145.92 153.91 167.36 164.14 161.59
Cash Flow Ratios
Operating Cash Flow Per Share
 2.42 2.83 1.51 1.99 1.38
Free Cash Flow Per Share
 1.63 2.01 0.45 1.06 0.16
CapEx Per Share
 0.79 0.82 1.06 0.94 1.22
Free Cash Flow to Operating Cash Flow
 0.67 0.71 0.30 0.53 0.12
Dividend Paid and CapEx Coverage Ratio
 2.46 2.84 1.18 1.76 1.00
Capital Expenditure Coverage Ratio
 3.06 3.45 1.42 2.13 1.13
Operating Cash Flow Coverage Ratio
 0.26 0.28 0.18 0.29 0.24
Operating Cash Flow to Sales Ratio
 0.06 0.08 0.05 0.07 0.05
Free Cash Flow Yield
16.19%16.74%5.08%8.38%1.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.96 14.27 12.39 20.18 15.76
Price-to-Sales (P/S) Ratio
 0.26 0.32 0.27 0.42 0.34
Price-to-Book (P/B) Ratio
 1.14 1.39 1.06 1.60 1.23
Price-to-Free Cash Flow (P/FCF) Ratio
 6.18 5.97 19.70 11.93 57.08
Price-to-Operating Cash Flow Ratio
 4.16 4.24 5.85 6.32 6.62
Price-to-Earnings Growth (PEG) Ratio
 0.67 0.78 0.85 2.93 1.67
Enterprise Value Multiple
 5.46 6.90 5.77 7.28 6.63
Enterprise Value
 2.85B 3.25B 2.47B 2.87B 2.21B
EV to EBITDA
 5.46 6.90 5.77 7.28 6.63
EV to Sales
 0.48 0.59 0.50 0.64 0.55
EV to Free Cash Flow
 11.69 10.86 37.04 18.26 92.55
EV to Operating Cash Flow
 7.87 7.71 11.00 9.68 10.74
Tangible Book Value Per Share
 8.09 7.87 7.63 7.33 6.94
Shareholders’ Equity Per Share
 8.82 8.60 8.28 7.89 7.46
Tax and Other Ratios
Effective Tax Rate
 0.15 0.14 0.06 -0.01 -0.10
Revenue Per Share
 39.49 36.98 33.15 30.00 26.86
Net Income Per Share
 0.92 0.84 0.71 0.62 0.58
Tax Burden
 0.85 0.86 0.94 1.01 1.10
Interest Burden
 0.58 0.61 0.52 0.47 0.53
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.21 0.08 0.06 <0.01 <0.01
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 0.00
Income Quality
 2.63 3.38 2.13 3.19 2.38
Currency in BRL